One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Dialysis Facility Closures: Fraying a Fragile Lifeline for People With Kidney Failure
Unemployment and Inability to Work: A Continued Worldwide Challenge for People Receiving Dialysis
Dialysis Facility Closures in the US From 2018 to 2024: A Serial Cross-Sectional Study
Paid Employment and Ability to Work Among People Receiving Dialysis: A Systematic Review of Qualitative Studies
Experiences and Management of People With a Failing Kidney Transplant: Findings From the IN-FAKT Study
Cancer Incidence in People With Glomerular Disease: A Population-Level Study
Association of Autosomal Dominant Polycystic Kidney Disease With Incident Aortic Dissection or Aneurysm
Association of the Timing of Acute Declines in Kidney Function in Acute Heart Failure With Cardiovascular and Kidney Outcomes
National All-Cause Mortality Trends Among Adults With and Without CKD in the United States, 1999-2019
Representation of Adults With CKD in Major Endovascular Stroke Trials
A Survey of Home Dialysis Competency, Exposure, and Barriers Among Nephrology Fellows in the United States
Is There a Role for Pentoxifylline in Diabetic Kidney Disease? A Mini Review
Vaccinations to Prevent Infections in Adult Individuals With CKD and After Kidney Transplantation: A Review
Implications of Acute Kidney Injury Requiring Dialysis Versus End-Stage Kidney Disease Status
The Role of Altered Mineral Metabolism in Kidney Stone Disease: Is Vitamin D the Key?
Unmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis Anticoagulation
Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation
In Reply to “Unmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis Anticoagulation� and “Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation�
Sodium/Glucose Cotransporter 2 Inhibitors and Renal Oxygenation: Rethinking the Role of Uromodulin
